Chapter/Section Purchase

1 Polymer Drug Conjugates Market Overview
1.1 Product Overview and Scope of Polymer Drug Conjugates
1.2 Polymer Drug Conjugates Segment by Type
1.2.1 Global Polymer Drug Conjugates Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Polymer-Dox Conjugates
1.2.3 Polymer-Paclitaxel Conjugates
1.2.4 Polymer-Camptothecin Conjugates
1.2.5 Polymer-Platinate Conjugates
1.3 Polymer Drug Conjugates Segment by Application
1.3.1 Global Polymer Drug Conjugates Sales Comparison by Application: (2023-2030)
1.3.2 Cancer Treatment
1.3.3 Leukmia
1.3.4 Hepatitis
1.3.5 Others
1.4 Global Polymer Drug Conjugates Market Size Estimates and Forecasts
1.4.1 Global Polymer Drug Conjugates Revenue 2018-2030
1.4.2 Global Polymer Drug Conjugates Sales 2018-2030
1.4.3 Polymer Drug Conjugates Market Size by Region: 2018 Versus 2022 Versus 2030
2 Polymer Drug Conjugates Market Competition by Manufacturers
2.1 Global Polymer Drug Conjugates Sales Market Share by Manufacturers (2018-2023)
2.2 Global Polymer Drug Conjugates Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Polymer Drug Conjugates Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Polymer Drug Conjugates Manufacturing Sites, Area Served, Product Type
2.5 Polymer Drug Conjugates Market Competitive Situation and Trends
2.5.1 Polymer Drug Conjugates Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Polymer Drug Conjugates Players Market Share by Revenue
2.5.3 Global Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polymer Drug Conjugates Retrospective Market Scenario by Region
3.1 Global Polymer Drug Conjugates Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Polymer Drug Conjugates Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Polymer Drug Conjugates Market Facts & Figures by Country
3.3.1 North America Polymer Drug Conjugates Sales by Country
3.3.2 North America Polymer Drug Conjugates Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Polymer Drug Conjugates Market Facts & Figures by Country
3.4.1 Europe Polymer Drug Conjugates Sales by Country
3.4.2 Europe Polymer Drug Conjugates Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Polymer Drug Conjugates Market Facts & Figures by Region
3.5.1 Asia Pacific Polymer Drug Conjugates Sales by Region
3.5.2 Asia Pacific Polymer Drug Conjugates Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Polymer Drug Conjugates Market Facts & Figures by Country
3.6.1 Latin America Polymer Drug Conjugates Sales by Country
3.6.2 Latin America Polymer Drug Conjugates Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Polymer Drug Conjugates Market Facts & Figures by Country
3.7.1 Middle East and Africa Polymer Drug Conjugates Sales by Country
3.7.2 Middle East and Africa Polymer Drug Conjugates Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Polymer Drug Conjugates Historic Market Analysis by Type
4.1 Global Polymer Drug Conjugates Sales Market Share by Type (2018-2023)
4.2 Global Polymer Drug Conjugates Revenue Market Share by Type (2018-2023)
4.3 Global Polymer Drug Conjugates Price by Type (2018-2023)
5 Global Polymer Drug Conjugates Historic Market Analysis by Application
5.1 Global Polymer Drug Conjugates Sales Market Share by Application (2018-2023)
5.2 Global Polymer Drug Conjugates Revenue Market Share by Application (2018-2023)
5.3 Global Polymer Drug Conjugates Price by Application (2018-2023)
6 Key Companies Profiled
6.1 3S Bio
6.1.1 3S Bio Corporation Information
6.1.2 3S Bio Description and Business Overview
6.1.3 3S Bio Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3S Bio Polymer Drug Conjugates Product Portfolio
6.1.5 3S Bio Recent Developments/Updates
6.2 Abeona Therapeutics
6.2.1 Abeona Therapeutics Corporation Information
6.2.2 Abeona Therapeutics Description and Business Overview
6.2.3 Abeona Therapeutics Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abeona Therapeutics Polymer Drug Conjugates Product Portfolio
6.2.5 Abeona Therapeutics Recent Developments/Updates
6.3 Abramson Cancer Center
6.3.1 Abramson Cancer Center Corporation Information
6.3.2 Abramson Cancer Center Description and Business Overview
6.3.3 Abramson Cancer Center Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abramson Cancer Center Polymer Drug Conjugates Product Portfolio
6.3.5 Abramson Cancer Center Recent Developments/Updates
6.4 Access Pharmaceuticals
6.4.1 Access Pharmaceuticals Corporation Information
6.4.2 Access Pharmaceuticals Description and Business Overview
6.4.3 Access Pharmaceuticals Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Access Pharmaceuticals Polymer Drug Conjugates Product Portfolio
6.4.5 Access Pharmaceuticals Recent Developments/Updates
6.5 Adama
6.5.1 Adama Corporation Information
6.5.2 Adama Description and Business Overview
6.5.3 Adama Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Adama Polymer Drug Conjugates Product Portfolio
6.5.5 Adama Recent Developments/Updates
6.6 Eyetech
6.6.1 Eyetech Corporation Information
6.6.2 Eyetech Description and Business Overview
6.6.3 Eyetech Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eyetech Polymer Drug Conjugates Product Portfolio
6.6.5 Eyetech Recent Developments/Updates
6.7 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ferring Polymer Drug Conjugates Product Portfolio
6.7.5 Ferring Recent Developments/Updates
6.8 Flamel Technologies
6.8.1 Flamel Technologies Corporation Information
6.8.2 Flamel Technologies Description and Business Overview
6.8.3 Flamel Technologies Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Flamel Technologies Polymer Drug Conjugates Product Portfolio
6.8.5 Flamel Technologies Recent Developments/Updates
6.9 Genentech
6.9.1 Genentech Corporation Information
6.9.2 Genentech Description and Business Overview
6.9.3 Genentech Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Genentech Polymer Drug Conjugates Product Portfolio
6.9.5 Genentech Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GlaxoSmithKline Polymer Drug Conjugates Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Gowan
6.11.1 Gowan Corporation Information
6.11.2 Gowan Polymer Drug Conjugates Description and Business Overview
6.11.3 Gowan Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Gowan Polymer Drug Conjugates Product Portfolio
6.11.5 Gowan Recent Developments/Updates
6.12 Gynecologic Oncology Group Foundation
6.12.1 Gynecologic Oncology Group Foundation Corporation Information
6.12.2 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Description and Business Overview
6.12.3 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Product Portfolio
6.12.5 Gynecologic Oncology Group Foundation Recent Developments/Updates
6.13 JenKem Technology
6.13.1 JenKem Technology Corporation Information
6.13.2 JenKem Technology Polymer Drug Conjugates Description and Business Overview
6.13.3 JenKem Technology Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.13.4 JenKem Technology Polymer Drug Conjugates Product Portfolio
6.13.5 JenKem Technology Recent Developments/Updates
6.14 Landec
6.14.1 Landec Corporation Information
6.14.2 Landec Polymer Drug Conjugates Description and Business Overview
6.14.3 Landec Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Landec Polymer Drug Conjugates Product Portfolio
6.14.5 Landec Recent Developments/Updates
6.15 Lipotek
6.15.1 Lipotek Corporation Information
6.15.2 Lipotek Polymer Drug Conjugates Description and Business Overview
6.15.3 Lipotek Polymer Drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Lipotek Polymer Drug Conjugates Product Portfolio
6.15.5 Lipotek Recent Developments/Updates
7 Polymer Drug Conjugates Manufacturing Cost Analysis
7.1 Polymer Drug Conjugates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Polymer Drug Conjugates
7.4 Polymer Drug Conjugates Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Polymer Drug Conjugates Distributors List
8.3 Polymer Drug Conjugates Customers
9 Polymer Drug Conjugates Market Dynamics
9.1 Polymer Drug Conjugates Industry Trends
9.2 Polymer Drug Conjugates Market Drivers
9.3 Polymer Drug Conjugates Market Challenges
9.4 Polymer Drug Conjugates Market Restraints
10 Global Market Forecast
10.1 Polymer Drug Conjugates Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Polymer Drug Conjugates by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Polymer Drug Conjugates by Type (2023-2030)
10.2 Polymer Drug Conjugates Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Polymer Drug Conjugates by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Polymer Drug Conjugates by Application (2023-2030)
10.3 Polymer Drug Conjugates Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Polymer Drug Conjugates by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Polymer Drug Conjugates by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer